PROMETIC BIOSCIENCES LTD DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

Related Companies

Prometic LifeSciences Inc

ProMetic Life Sciences Inc. is a long established publicly traded (TSX symbol: PLI, OTCQX: PFSCF), biopharmaceutical corporation with a globally recognized expertise in bioseparations, plasma-derived therapeutics and small-molecule drug development. ProMetic offers its state of the art technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens to a growing base of indu...

ProMetic Life Sciences Inc. is a long established publicly traded (TSX symbol: PLI, OTCQX: PFSCF), biopharmaceutical corporation with a globally recognized expertise in bioseparations, plasma-derived therapeutics and small-molecule drug development. ProMetic offers its state of the art technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens to a growing base of industry leaders and uses its own affinity technology that provides for highly efficient extraction and purification of therapeutic proteins from human plasma in order to develop best-in-class therapeutics. ProMetic is also active in developing its own novel therapeutics products targeting unmet medical needs in the field of fibrosis, anemia, neutropenia, cancer, and autoimmune disease/inflammation as well as certain nephropathies. ProMetic’s business is organized into two distinct operating segments; Protein Technologies and Therapeutics, supported by a Head Office in Laval, Canada, R&D facilities in the UK, the USA and Canada as well as manufacturing facilities in the UK and business development activities in the USA, Europe and Asia.